Test–Retest Reliability of the Multiple Sleep Latency Test in Central Disorders of Hypersomnolence

Study Objectives To assess the test-retest reliability of the polysomnography-multiple sleep latency test (PSG-MSLT) diagnostic classification and measures and to study the determinants of its variability in patients with narcolepsy type 1 (NT1) or with noncataplectic central disorders of hypersomnolence (NCHS): type 2 (NT2), idiopathic hypersomnia (IH), and unspecified hypersomnolence (unspecified excessive daytime sleepiness [UnsEDS]). Methods PSG-MSLT in drug-free conditions was administered twice (median interval of 1.9 years) in 22 patients with NT1 (10 males, median age 31.2 years) and 75 patients with NCHS (32 males, median age 25.7 years). Results At the first PSG-MSLT, patients with NCHS were classified as having NT2 (22.7%), IH (26.7%), or UnsEDS (50.6%). A positive PSG-MSLT was confirmed in 72.7% of NT1. The classification consistency at retesting was significantly lower for the NT2 (47.1%), IH (25.0%), and UnsEDS (42.1%) categories than NT1 (81.3%). The between-test mean sleep latency (MSL) variability was significantly different in NT1 and NCHS, with higher changes in NT2 and lower in NT1. A longer test-retest interval was associated with improved MSL and MSLT normalization. Between-test variations in SOREMP number were associated with changes in nocturnal REM sleep parameters and MSL. No association was found with the clinical decision to repeat the evaluation or the disease clinical course. Conclusion The PSG-MSLT measures and classification are not stable in patients with NCHS, with frequent diagnostic changes, particularly for NT2 and IH, compared with NT1. MSLT needs to be repeated at regular intervals to confirm a stable hypersomnia and provide an accurate diagnosis of NT2 and IH.

[1]  I. Jaussent,et al.  Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy , 2017, Sleep.

[2]  J. H. Lee,et al.  Different fates of excessive daytime sleepiness: survival analysis for remission , 2016, Acta neurologica Scandinavica.

[3]  I. Jaussent,et al.  Absence of γ‐aminobutyric acid‐a receptor potentiation in central hypersomnolence disorders , 2016, Annals of neurology.

[4]  J. Siegel,et al.  Cataplexy—clinical aspects, pathophysiology and management strategy , 2014, Nature Reviews Neurology.

[5]  E. Mignot,et al.  Challenges in diagnosing narcolepsy without cataplexy: a consensus statement. , 2014, Sleep.

[6]  G. Mayer,et al.  The MSLT: More objections than benefits as a diagnostic gold standard? , 2014, Sleep.

[7]  T. Young,et al.  Narcolepsy and predictors of positive MSLTs in the Wisconsin Sleep Cohort. , 2014, Sleep.

[8]  D. Rye,et al.  Test-retest reliability of the multiple sleep latency test in narcolepsy without cataplexy and idiopathic hypersomnia. , 2013, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[9]  T. Young,et al.  Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency. , 2013, JAMA neurology.

[10]  M. Ohayon,et al.  Hypersomnia and depressive symptoms: methodological and clinical aspects , 2013, BMC Medicine.

[11]  Jacqueline A. Fairley,et al.  Modulation of Vigilance in the Primary Hypersomnias by Endogenous Enhancement of GABAA Receptors , 2012, Science Translational Medicine.

[12]  J. Schwartz,et al.  Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions. , 2012, Sleep.

[13]  L. Sharples,et al.  Idiopathic hypersomnia: a study of 77 cases. , 2007, Sleep.

[14]  E. Mignot,et al.  Narcolepsy with cataplexy , 2007, The Lancet.

[15]  C. Drake,et al.  The prevalence of multiple sleep-onset REM periods in a population-based sample. , 2006, Sleep.

[16]  T. Young,et al.  Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults. , 2006, Brain : a journal of neurology.

[17]  J. Touchon,et al.  Effect of age on MSLT results in patients with narcolepsy–cataplexy , 2004, Neurology.

[18]  M. Aldrich,et al.  Idiopathic hypersomnia : A series of 42 patients , 1997 .

[19]  D. Bruck,et al.  A comparison of idiopathic hypersomnia and narcolepsy-cataplexy using self report measures and sleep diary data. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[20]  T. Roth,et al.  The reliability of the diagnostic features in patients with narcolepsy , 1996, Biological Psychiatry.

[21]  C. Guilleminault,et al.  Monoamine interactions in narcolepsy and hypersomnia: reanalysis. , 1989, Sleep.

[22]  T. Roehrs,et al.  Test-retest reliability of the MSLT. , 1988, Sleep.

[23]  M. Carskadon,et al.  Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. , 1986, Sleep.

[24]  E. Mignot,et al.  Longitudinal associations of hypersomnolence and depression in the Wisconsin Sleep Cohort Study. , 2017, Journal of affective disorders.

[25]  R. Rosa,et al.  The clinical use of the MSLT and MWT. , 2005, Sleep.

[26]  M. Littner,et al.  Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. , 2005, Sleep.

[27]  M. Thorpy.  The clinical use of the Multiple Sleep Latency Test. The Standards of Practice Committee of the American Sleep Disorders Association. , 1992, Sleep.